Medical Properties Trust financials
$3.51+0.29%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 |
|---|---|---|
| Revenue | $259.3M | $241.8M |
| Gross profit | $259.3M | $241.8M |
| Gross margin | 100.0% | 100.0% |
| Operating income | $127.1M | $110.9M |
| Net income | -$2.6M | $32.8M |
| Net margin | −1.0% | 13.6% |
| Diluted EPS | $-0.01 | $0.05 |
| EBITDA | $217.5M | $203.3M |
| Operating cash flow | $62.4M | -$14.3M |
| Free cash flow | $55.0M | -$27.0M |
| Diluted shares | 598.0M | 597.7M |
Balance sheet
| Period end | Jun 30 | Mar 31 |
|---|---|---|
| Cash & equivalents | $396.6M | $425.0M |
| Short-term investments | $0.00 | $0.00 |
| Total debt | $9.70B | $9.66B |
| Total assets | $14.75B | $14.76B |
| Total liabilities | $10.25B | $10.22B |
| Shareholders' equity | $4.50B | $4.55B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology